Coloma Jason V
Known title: Chief Executive OfficerCIK: 0001676170
Associated companies
Transaction History
| MAZE | ▼ Sell | Open Market | 2,593 | $70K | 10/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 31,908 | $862K | 10/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 11,282 | $293K | 9/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 129 | $3K | 9/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 9,852 | $260K | 9/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,375 | $37K | 9/2/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 50,000 | $0 | 9/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 2,593 | $68K | 9/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 31,908 | $839K | 9/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 2,439 | $65K | 8/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 154 | $4K | 8/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 30,304 | $810K | 8/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,604 | $43K | 8/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 2,593 | $78K | 7/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 30,311 | $908K | 7/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,597 | $49K | 7/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 23,865 | $622K | 6/23/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 2,040 | $53K | 6/22/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,953 | $51K | 6/22/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 553 | $15K | 6/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 6,090 | $160K | 6/1/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 25,582 | $666K | 5/26/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 4,504 | $117K | 5/22/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 2,478 | $64K | 5/22/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,822 | $47K | 5/15/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 116 | $3K | 5/15/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pompe Disease Market Expected to Grow Through 2036
A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.
Pompe Disease Market Expected to Grow Through 2036. A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.